A study by Wagener and colleagues found that there were chitin-dependent pathways of NOD2 activation that lead to interleukin-10 secretion and promote intestinal homeostasis,36 leading to the hypothesis that the mycobiota of CD patients with NOD2 mutations would differ from that of wild-type individuals. The gene discussed is NOD2; the disease is Cowden disease.